Unveiling Biochemically Responsive MR Probes for Precision Beyond LimitsThe NeedIn the realm of medical diagnostics, the need for precise and non-invasive detection of molecular-level pathology has been a longstanding challenge. Traditional imaging techniques often fall short in providing detailed insights into biological processes at this scale. To address this gap, there is a critical demand for advanced biochemically responsive magnetic resonance imaging (MRI) probes that can offer unparalleled accuracy in detecting, quantifying, and mapping pathology at the molecular level. The TechnologyIntroducing a groundbreaking solution, our technology leverages stable iron complexes that dynamically switch between high-spin monomeric and antiferromagnetically coupled dimeric species within the pH range encountered within human pathophysiology. This innovation enables a significant change in the relaxivity of the probe, providing a robust and biochemically responsive MR imaging agent. The iron complexes ensure a clear "off/on" effect, where the antiferromagnetic species exhibits low relaxivity, and the monomeric complex boasts high relaxivity, overcoming the limitations of traditional Gd-based probes. Commercial Applications
Benefits/Advantages
In summary, our biochemically responsive MR imaging probes represent a paradigm shift in medical diagnostics, providing a versatile and sensitive tool for clinicians and researchers alike. With applications ranging from cancer detection to neurological imaging, our technology is poised to revolutionize the landscape of molecular-level pathology visualization. |
Tech IDT2023-046 CollegeLicensing ManagerDahlman, Jason "Jay" InventorsCategories |